Showing results (151-160 of 188) with videos related to
Sort By:
Pageof 19
Cancers|July 27, 2022
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry AnalysisViktoria Florentine Koehler, Pia Adam, Carmina Teresa Fuss, et al.Cancer Immunology, Immunotherapy : CII|April 17, 2025
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinomaLuc M Berclaz, Anton Burkhard-Meier, Axel Lechner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept StudyJohanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.Cancer Medicine|February 26, 2025
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched AnalysisLuc M Berclaz, Vindi Jurinovic, Anton Burkhard-Meier, et al.Oncotarget|October 22, 2016
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsKathrin Fielitz, Kristina Althoff, Katleen De Preter, et al.Clinical & Experimental Metastasis|February 29, 2024
Differentiation of benign and metastatic lymph nodes in soft tissue sarcomaAnton Burkhard-Meier, Vindi Jurinovic, Luc M Berclaz, et al.Journal of Cancer Research and Clinical Oncology|April 26, 2025
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysisAnton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, et al.Journal of Cancer Research and Clinical Oncology|August 7, 2023
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancerViktoria Florentine Koehler, Josefine Achterfeld, Natalie Sandner, et al.Ebiomedicine|February 3, 2019
Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolitesMelanie S Patzak, Vijayalakshmi Kari, Shilpa Patil, et al.Histopathology|April 8, 2014
Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumourChristian Koelsche, Leonille Schweizer, Marcus Renner, et al.Pageof 19